PTIX Insider Trading

Insider Ownership Percentage: 37.00%
Insider Buying (Last 12 Months): $6,480.00
Insider Selling (Last 12 Months): $0.00

Protagenic Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Protagenic Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Protagenic Therapeutics Share Price & Price History

Current Price: $0.70
Price Change: Price Decrease of -0.05 (-6.66%)
As of 07/19/2024 01:00 AM ET

This chart shows the closing price history over time for PTIX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Protagenic Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/12/2023Alexander K ArrowCFOBuy8,000$0.81$6,480.0045,815View SEC Filing Icon  
5/17/2022Alexander K ArrowCFOBuy23,000$0.71$16,330.00143,260View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Protagenic Therapeutics (NASDAQ:PTIX)

7.97% of Protagenic Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PTIX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Protagenic Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/12/2023FNY Investment Advisers LLC18,750$32K0.0%-75.0%0.434%Search for SEC Filing on Google Icon
2/1/2022FNY Investment Advisers LLC74,800$0.10M0.1%N/A0.441%Search for SEC Filing on Google Icon
1/10/2022FNY Investment Advisers LLC74,800$0.10M0.1%N/A0.441%Search for SEC Filing on Google Icon
11/15/2021Oracle Investment Management Inc.500,000$0.94M0.1%N/A2.980%Search for SEC Filing on Google Icon
8/16/2021Squarepoint Ops LLC19,718$57K0.0%N/A0.135%Search for SEC Filing on Google Icon
8/16/2021State Street Corp98,800$0.29M0.0%N/A0.675%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp22,485$65K0.0%N/A0.154%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC59,083$0.17M0.0%N/A0.403%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.20,783$60K0.0%N/A0.142%Search for SEC Filing on Google Icon
8/11/2021Susquehanna Fundamental Investments LLC12,900$37K0.0%N/A0.088%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Protagenic Therapeutics logo
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.
Read More on Protagenic Therapeutics

Today's Range

Now: $0.70
Low: $0.70
High: $0.79

50 Day Range

MA: $1.08
Low: $0.70
High: $1.80

52 Week Range

Now: $0.70
Low: $0.68
High: $2.22

Volume

10,961 shs

Average Volume

8,790 shs

Market Capitalization

$3.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.27

Who are the company insiders with the largest holdings of Protagenic Therapeutics?

Protagenic Therapeutics' top insider shareholders include:
  1. Alexander K Arrow (CFO)
Learn More about top insider investors at Protagenic Therapeutics.